The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Holland David since 2013.
This trader's CIK number is 1489532.
At the time of last reporting, Holland David was the Chief Marketing Officer & SVP of Alimera Sciences Inc. (stock ticker symbol ALIM).
Also see all insider trading activities at Alimera Sciences Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | ALIM | 5,000 | $20,390 | 0 | $0 | 0 | $0 |
| 2018 | ALIM | 0 | $0 | 51,000 | $62,028 | 0 | $0 |
| 2016 | ALIM | 0 | $0 | 0 | $0 | 27,971 | $37,201 |
| 2015 | ALIM | 0 | $0 | 5,000 | $27,799 | 5,000 | $6,650 |
| 2014 | ALIM | 0 | $0 | 60,000 | $377,549 | 60,000 | $99,325 |
| 2013 | ALIM | 0 | $0 | 30,000 | $124,020 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-11-03 | ALIM | Buy | 5,000 | 4.08 | 20,390 |
| 2018-01-18 | ALIM | Sale | 12,750 | 1.22 | 15,504 |
| 2018-01-19 | ALIM | Sale | 12,750 | 1.18 | 15,045 |
| 2018-01-16 | ALIM | Sale | 12,750 | 1.24 | 15,784 |
| 2018-01-17 | ALIM | Sale | 12,750 | 1.23 | 15,695 |
| 2016-10-11 | ALIM | Option Ex | 27,971 | 1.33 | 37,201 |
| 2015-01-02 | ALIM | Sale | 5,000 | 5.56 | 27,799 |
| 2015-01-02 | ALIM | Option Ex | 5,000 | 1.33 | 6,650 |
| 2014-12-01 | ALIM | Option Ex | 5,000 | 1.33 | 6,650 |
| 2014-12-01 | ALIM | Sale | 5,000 | 5.71 | 28,550 |
| 2014-11-03 | ALIM | Option Ex | 5,000 | 1.33 | 6,650 |
| 2014-11-03 | ALIM | Sale | 5,000 | 5.34 | 26,700 |
| 2014-10-01 | ALIM | Sale | 5,000 | 5.26 | 26,300 |
| 2014-10-01 | ALIM | Option Ex | 5,000 | 1.33 | 6,650 |
| 2014-09-02 | ALIM | Sale | 5,000 | 6.19 | 30,950 |
| 2014-09-02 | ALIM | Option Ex | 5,000 | 1.33 | 6,650 |
| 2014-08-01 | ALIM | Option Ex | 5,000 | 1.33 | 6,650 |
| 2014-08-01 | ALIM | Sale | 5,000 | 5.64 | 28,200 |
| 2014-07-01 | ALIM | Option Ex | 5,000 | 1.33 | 6,650 |
| 2014-07-01 | ALIM | Sale | 5,000 | 6.02 | 30,099 |
| 2014-06-02 | ALIM | Option Ex | 5,000 | 1.69 | 8,425 |
| 2014-06-02 | ALIM | Sale | 5,000 | 5.73 | 28,650 |
| 2014-05-01 | ALIM | Sale | 5,000 | 5.93 | 29,650 |
| 2014-05-01 | ALIM | Option Ex | 5,000 | 2.04 | 10,200 |
| 2014-04-01 | ALIM | Option Ex | 10,000 | 2.04 | 20,400 |
| 2014-04-01 | ALIM | Sale | 10,000 | 8.01 | 80,100 |
| 2014-03-03 | ALIM | Option Ex | 5,000 | 2.04 | 10,200 |
| 2014-03-04 | ALIM | Option Ex | 5,000 | 2.04 | 10,200 |
| 2014-03-03 | ALIM | Sale | 5,000 | 6.67 | 33,350 |
| 2014-03-04 | ALIM | Sale | 5,000 | 7.00 | 35,000 |
| 2013-05-17 | ALIM | Sale | 30,000 | 4.13 | 124,020 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Holland David (Chief Marketing Officer & SVP of Alimera Sciences Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.